荣泰健康(603579) - 2019 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders decreased by 0.84% to CNY 57,767,701.15 year-on-year[5] - Operating revenue decreased by 15.22% to CNY 511,128,118.88 compared to the same period last year[5] - Basic earnings per share decreased by 2.38% to CNY 0.41[7] - Total revenue for Q1 2019 was CNY 511,128,118.88, a decrease of 15.2% compared to CNY 602,891,432.15 in Q1 2018[35] - Operating profit for Q1 2019 was CNY 61,023,549.81, down from CNY 71,522,446.28 in Q1 2018, reflecting a decline of 14.0%[36] - Net profit for Q1 2019 was CNY 54,251,212.01, a decrease of 12.9% from CNY 62,157,137.93 in Q1 2018[36] - The total comprehensive income for Q1 2019 was CNY 53,863,777.13, compared to CNY 51,268,093.43 in Q1 2018, reflecting an increase of about 5.1%[41] Assets and Liabilities - Total assets increased by 2.82% to CNY 2,227,865,972.33 compared to the end of the previous year[5] - The total current assets reached RMB 1,674,068,833.20, compared to RMB 1,596,351,870.58 at the end of 2018, indicating an increase of about 4.9%[29] - Total liabilities were RMB 675,521,881.87, slightly up from RMB 668,669,353.07, reflecting a marginal increase of about 1.3%[30] - The company reported a current liability total of RMB 640,673,464.35, which is an increase from RMB 610,214,353.12, representing a growth of about 5.0%[30] - Long-term investments stood at RMB 42,608,437.64, slightly up from RMB 42,448,633.75, showing a growth of approximately 0.4%[29] - The company’s non-current assets totaled RMB 553,797,139.13, down from RMB 570,462,220.88, indicating a decrease of about 2.9%[29] Cash Flow - Net cash flow from operating activities increased by 150.49% to CNY 140,117,835.39 year-to-date[5] - Cash received from operating activities was adjusted to CNY 32.25 million after an increase of CNY 1.86 million[16] - Cash paid for investment activities was adjusted to CNY 28.43 million after a decrease of CNY 100 million[19] - Cash flow from operating activities generated a net amount of CNY 140,117,835.39, significantly higher than CNY 55,937,908.85 in Q1 2018, reflecting a growth of approximately 150.0%[43] - The total cash inflow from operating activities was CNY 662,222,564.45, down from CNY 705,140,536.34 in Q1 2018, a decrease of about 6.1%[42] - Cash outflow from operating activities totaled CNY 522,104,729.06, compared to CNY 649,202,627.49 in the previous year, showing a reduction of approximately 19.6%[43] Investments and Expenses - Research and development expenses decreased by 43.11% to CNY 17.78 million compared to the previous period[12] - Financial expenses dropped by 81.27% to CNY 4.93 million, mainly influenced by fluctuations in the USD exchange rate[12] - Other income surged by 402.67% to CNY 2.87 million, primarily due to an increase in government subsidies[12] - The company reported a decrease in operating costs to CNY 467,196,664.30 in Q1 2019, down from CNY 530,308,443.15 in Q1 2018, a decline of 11.9%[35] Changes in Cash and Equivalents - Cash and cash equivalents decreased by 49.78% to CNY 545,316,972.96 due to increased investment in financial products[13] - The cash and cash equivalents at the end of Q1 2019 were CNY 542,702,572.96, down from CNY 829,095,862.74 at the end of Q1 2018, a decrease of approximately 34.6%[44] - The company received CNY 9,713,069.65 in tax refunds during Q1 2019, a decrease from CNY 31,594,224.86 in Q1 2018, representing a decline of about 69.1%[42] Other Financial Metrics - The weighted average return on equity decreased by 0.37 percentage points to 3.80%[5] - Non-recurring gains and losses totaled CNY 15,024,521.52 for the period[9] - Tax payable decreased by 83.96% to CNY 4.58 million, mainly due to a reduction in income tax and individual income tax payable[12] - Deferred income decreased by 66.63% to CNY 1.75 million, primarily due to an increase in government grants related to assets[12]